CALRC - Overview: Calreticulin ex9mut Immunostain, Technical Component Only
Identifying the presence of CALR exon 9 frameshift alterations in myeloproliferative neoplasms
CD56 - Overview: CD56 Immunostain, Technical Component Only
Aiding in the identification of tumors with neuroendocrine differentiation Aiding in the identification of natural killer cell lineage in a subset of lymphomas
CD71 - Overview: CD71 Immunostain, Technical Component Only
Assessment of erythroid lineage
CD38 - Overview: CD38 Immunostain, Technical Component Only
Classification of lymphoproliferative and plasma cell proliferative disorders
CD25 - Overview: CD25 Immunostain, Technical Component Only
Classification of lymphomas
CD34I - Overview: CD34 Immunostain, Technical Component Only
A marker of immaturity in the setting of acute myeloid leukemia or B-cell lymphoblastic leukemia Diagnosis of gastrointestinal stromal tumors, solitary fibrous tumors, and angiosarcomas
CARNU - Overview: Carnitine, Random, Urine
Evaluation of patients with a clinical suspicion of a wide range of conditions including organic acidemias and fatty acid oxidation disorders Monitoring carnitine treatment
CO4D - Overview: Complement 4d Immunostain, Technical Component Only
Identification of antibody-mediated transplant rejection
FXCH - Overview: Coagulation Factor X Chromogenic Activity Assay, Plasma
Monitoring warfarin anticoagulant therapy, especially in patients whose plasma contains lupus anticoagulants that interfere with baseline prothrombin time/international normalized ratio and in patients receiving the drug Argatroban who are...
CYC1 - Overview: Cyclin D1 Immunostain, Technical Component Only
Classification of low-grade B-cell lymphomas
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.